von Willebrand Disease Profile Technical Interpretation
Use
The technical interpretation of the von Willebrand factor profile test is vital for detecting deficiencies or abnormalities in von Willebrand factor (VWF), which plays a crucial role in blood coagulation. This test assists in identifying subtypes of von Willebrand disease (VWD), such as type 1, type 2 variants, or type 3. Type 1 is the most common, while type 3 is rare. It helps in the clinical management of bleeding disorders by providing detailed insights into VWF functionality and its interactions with factor VIII, which are critical in forming hemostatic plugs and stabilizing blood clots.
Special Instructions
Not provided.
Limitations
This test is not useful for detecting hemophilia carriers or differentiating between type 2A and 2B VWD or platelet-type VWD, which requires additional testing like ristocetin-induced platelet aggregation. Low normal levels of VWF antigen or activity do not exclude VWD, and repeat testing may be needed for diagnosis confirmation, particularly in cases of mild type 1 VWD. It should be noted that external conditions such as recent transfusion, therapy, or use of estrogens can affect VWF levels.
New York Approved
Methodology
Other
Biomarkers
Factor VIII
OtherVon Willebrand Factor (VWF)
Protein
LOINC Codes
- 48595-3 - von Willebrand eval PPP-Imp
- 48595-3 - von Willebrand eval PPP-Imp
Result Turnaround Time
7-12 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
Not provided
Minimum Volume
1 mL
Collection Instructions
Only orderable as part of a profile. For more information see AVWPR / von Willebrand Disease Profile, Plasma.
Causes for Rejection
Gross hemolysis, gross lipemia, gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |